nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States
|
Santoni, Matteo |
|
|
19 |
2 |
p. e84-e91 |
artikel |
2 |
Clinical Considerations and Prognosis of Well-Differentiated Neuroendocrine Tumor Occurring Within a Renal Teratoma—A Case Series
|
Ungerer, Garrett |
|
|
19 |
2 |
p. e72-e77 |
artikel |
3 |
Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms
|
Yi, Zhenglin |
|
|
19 |
2 |
p. 155-161 |
artikel |
4 |
COVID-19 in Patients With Renal Cell Carcinoma in the Russian Federation
|
Tsimafeyeu, Ilya |
|
|
19 |
2 |
p. e69-e71 |
artikel |
5 |
Editorial Board
|
|
|
|
19 |
2 |
p. A1 |
artikel |
6 |
Impact of COVID-19 Pandemic on Health-Related Quality of Life in Uro-oncologic Patients: What Should We Wait For?
|
Greco, Francesco |
|
|
19 |
2 |
p. e63-e68 |
artikel |
7 |
Improving the Stratification of Patients With Intermediate-risk Prostate Cancer
|
Stolzenbach, Lara Franziska |
|
|
19 |
2 |
p. e120-e128 |
artikel |
8 |
Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab
|
Fujiwara, Ryo |
|
|
19 |
2 |
p. e78-e83 |
artikel |
9 |
Neoadjuvant Versus Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Microsimulation Model
|
Hird, Amanda E. |
|
|
19 |
2 |
p. e135-e147 |
artikel |
10 |
Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials
|
Marconi, Lorenzo |
|
|
19 |
2 |
p. e92-e99 |
artikel |
11 |
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program
|
Diamantopoulos, Leonidas N. |
|
|
19 |
2 |
p. 144-154 |
artikel |
12 |
Safety, Efficacy, and Impact on Quality of Life of Palliative Robotic Cystectomy for Advanced Prostate Cancer
|
Bhanvadia, Raj R. |
|
|
19 |
2 |
p. e129-e134 |
artikel |
13 |
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer
|
Di Gianfrancesco, Luca |
|
|
19 |
2 |
p. e100-e119 |
artikel |
14 |
Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients
|
Wenzel, Mike |
|
|
19 |
2 |
p. 135-143 |
artikel |
15 |
Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience
|
Hoffman-Censits, Jean |
|
|
19 |
2 |
p. 176-181 |
artikel |
16 |
Stage and Grade Migration in Prostate Cancer Treated With Radical Prostatectomy in a Large German Multicenter Cohort
|
Boehm, Katharina |
|
|
19 |
2 |
p. 162-166.e1 |
artikel |
17 |
Summary from the Kidney Cancer Association’s Inaugural Think Thank: Coalition for a Cure
|
Rini, Brian |
|
|
19 |
2 |
p. 167-175 |
artikel |
18 |
Systemic Analysis and Review of Nivolumab-ipilimumab Combination as a Rescue Strategy for Renal Cell Carcinoma After Treatment With Anti–PD-1/PD-L1 Therapy
|
Carril-Ajuria, Lucia |
|
|
19 |
2 |
p. 95-102 |
artikel |
19 |
Systemic Therapies for the Management of Non–Clear Cell Renal Cell Carcinoma: What Works, What Doesn’t, and What the Future Holds
|
Zoumpourlis, Panagiotis |
|
|
19 |
2 |
p. 103-116 |
artikel |
20 |
Table of contents
|
|
|
|
19 |
2 |
p. A3-A6 |
artikel |
21 |
The 2021 Variant Histology Issue
|
Hsieh, James J. |
|
|
19 |
2 |
p. 93-94 |
artikel |
22 |
Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens
|
Do, Olivia A. |
|
|
19 |
2 |
p. 125-134 |
artikel |
23 |
Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma
|
Deuker, Marina |
|
|
19 |
2 |
p. 117-124 |
artikel |